New radiation-free imaging method 'effectively diagnoses cancer'
2/19/2014
Standard imaging techniques, such as PET and CT scans, are used to assess the development of cancer in children. However, these imaging methods can expose children to radiation that increases their risk of secondary cancers later in life. Now, new research has detailed a new whole-body imaging technique that could eliminate this risk.
Starving melanoma cells may slow tumor growth
2/19/2014
New research suggests melanoma skin cancer may be controllable by starving its cells. Building on previous success with prostate cancer cells, scientists in Australia showed they could stop cell growth by blocking the pumps that melanoma cells use to acquire an essential cell nutrient.It is still very early days, as the method has only been tested in lab-grown cells.
Starving melanoma cells may slow tumor growth
2/19/2014
New research suggests melanoma skin cancer may be controllable by starving its cells. Building on previous success with prostate cancer cells, scientists in Australia showed they could stop cell growth by blocking the pumps that melanoma cells use to acquire an essential cell nutrient.It is still very early days, as the method has only been tested in lab-grown cells.
HIV drug used to reverse effects of virus that causes cervical cancer
2/19/2014
A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.
New treatment proposed to prevent devastating intestinal inflammation in cancer patients
2/19/2014
Experimental work pointing to a therapy for alleviating mucositis - a common, severe side effect of chemotherapy and irradiation of cancer patients or patients prepared for bone marrow transplantation - has been achieved by an international team of researchers from the US and Israel headed by scientists at the Hebrew University of Jerusalem.
Published study validates MammaPrint test for long-term prediction of breast cancer outcome
2/19/2014
A newly published study concludes that the MammaPrint® breast cancer test can accurately stratify a woman's breast cancer risk for up to 25 years after she is first diagnosed with the disease. U.S. and Dutch researchers reported the longest-term follow-up study of its kind that confirms the durable accuracy of a unique genomic test for early-stage breast cancer.
HIV drug used to reverse effects of virus that causes cervical cancer
2/19/2014
A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.
Published study validates MammaPrint test for long-term prediction of breast cancer outcome
2/19/2014
A newly published study concludes that the MammaPrint® breast cancer test can accurately stratify a woman's breast cancer risk for up to 25 years after she is first diagnosed with the disease. U.S. and Dutch researchers reported the longest-term follow-up study of its kind that confirms the durable accuracy of a unique genomic test for early-stage breast cancer.
Infected Tasmanian Devils reveal how cancer cells evolve in response to humans
2/19/2014
Tasmanian Devil Facial Tumour Disease (DFTD) has ravaged the world's largest carnivorous marsupial since it emerged in 1996, resulting in a population decline of over 90%.
Anaplastic thyroid carcinoma (ATC) is an aggressive type of cancer with a poor prognosis for which there is currently no effective treatment. Researchers from the National University of Singapore (NUS) have discovered for the first time that an epithelial basement membrane protein, called laminin-5 gamma-2 (LAMC2), has the potential to be an ideal target for the treatment of ATC.